WHO chief calls lockdowns blunt instrument

▴ who-chief-calls-lockdowns-blunt-instrument
WHO Director-General Tedros Adhanom Ghebreyesus also said that the Covid-19 pandemic has underscored the urgency of addressing non-communicable diseases

Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO) called lockdowns "a blunt instrument" on Friday. He went on to add that further nationwide lockdowns can be avoided with the right mix of targeted and tailored measures.

"Several countries are using a data-driven approach to drive a targeted response," Ghebreyesus said adding that non-communicable diseases and their risk factors are increasing vulnerability to Covid-19 infection.

Addressing a virtual media briefing, the WHO Director-General also stated how the pandemic has underscored the urgency of addressing non-communicable diseases and their risk factors. "Finding effective therapeutics for these patients is a high priority," he reiterated.

The World Health Organisation has issued a new set of guidelines on the use of corticosteroids to treat patients infected with severe Covid-19. It has also recommended the use of corticosteroids only in the case of patients who are severely or critically ill.

During the briefing, Ghebreyesus also talked about a vaccine strategy. He said, "If and when we have an effective vaccine, we must also use it effectively.

Initially, when supply is limited, priority must be given to vaccinating essential workers and those most at risk. In other words, vaccinating some people in all countries, rather than all people in some countries. I will repeat again: vaccine nationalism will prolong the pandemic, not shorten it."

"We are delighted that 78 high and upper-middle countries and economies have now confirmed they will participate in the COVAX facility, and the number is growing. I urge those who have not yet joined to do so by September 18," WHO Director-General Tedros Adhanom Ghebreyesus said.

Tags : #WHO #Chief #Blunt #Instrument

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024